SEC Form 4
Orchestra BioMed Holdings, Inc. (OBIO) insider trading
In the 12 months to Nov 10, 2026, 2 OBIO insiders reported open-market sales of $439.2K across 7 filings; 6 insiders bought $509.9K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $439.2K
- 7 filings · 2 insiders
- Open-market purchases
- $509.9K
- 13 filings
- Pre-arranged sales (10b5-1)
- 6 of 7
- $439.1K of $439.2K sold (100%)
Who traded OBIO, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
OBIO daily close from Nov 10, 2025 to Nov 9, 2026, between $3.49 and $6.35, last $5.70. 7 sale and 13 purchase filings by 7 insiders, marked at their filing dates. Darren Sherman, Officer (see filing): sold $439.1K and bought $10.7K across 7 filings, first filed Jun 2, 2026, last Nov 3, 2026. Eric S. Fain, Director: bought $182.6K across 2 filings, first filed May 18, 2026, last Nov 9, 2026. David P. Hochman, Officer (see filing): bought $174.2K across 6 filings, first filed Nov 17, 2025, last Nov 9, 2026. David Pacitti, Director: bought $100.0K across 1 filing, first filed Nov 9, 2026, last Nov 9, 2026. Jason Aryeh, Director: bought $37.5K across 2 filings, first filed May 19, 2026, last May 20, 2026. Andrew Lawrence Taylor, Chief Financial Officer: bought $5.0K across 1 filing, first filed Nov 9, 2026, last Nov 9, 2026. Roderick Wong, 10% owner: sold $132 across 1 filing, first filed Apr 29, 2026, last Apr 29, 2026.
Largest mark · tap a row for others
Eric S. Fain · Director
Purchase $100,000
20,000 shares at $5.00 avg
Filed Nov 9, 2026
Close on filing date $5.70
Darren Sherman · Officer (see filing)
Officer (see filing)
$439.1K sold$10.7K boughtEric S. Fain · Director
Director
$182.6K boughtDavid P. Hochman · Officer (see filing)
Officer (see filing)
$174.2K boughtDavid Pacitti · Director
Director
$100.0K boughtJason Aryeh · Director
Director
$37.5K boughtAndrew Lawrence Taylor · Chief Financial Officer
Chief Financial Officer
$5.0K boughtRoderick Wong · 10% owner
10% owner
$132 soldOpen-market trades
20 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Darren Sherman | Officer (see filing) | $439.1K | $10.7K | 7 | 100% of sales | |
| Eric S. Fain | Director | — | $182.6K | 2 | — | |
| David P. Hochman | Officer (see filing) | — | $174.2K | 6 | — | |
| David Pacitti | Director | — | $100.0K | 1 | — | |
| Jason Aryeh | Director | — | $37.5K | 2 | — | |
| Andrew Lawrence Taylor | Chief Financial Officer | — | $5.0K | 1 | — | |
| Roderick Wong | 10% owner | $132 | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Andrew Lawrence Taylor Chief Financial Officer | Purchase | 1,000 | $5.00 | $5.0K | 590,989 | |
traded | David P. Hochman Officer (see filing) | Purchase | 5,000 | $5.00 | $25.0K | 437,916 | |
traded | David Pacitti Director | Purchase | 20,000 | $5.00 | $100.0K | 74,750 | |
traded | Eric S. Fain Director | Purchase | 20,000 | $5.00 | $100.0K | 119,630 | |
traded | Darren Sherman Officer (see filing) | SalePre-arranged (10b5-1) | 15,000 | $5.74 | $86.1K | 1,104,402 | |
traded | Darren Sherman Officer (see filing) | SalePre-arranged (10b5-1) | 15,000 | $6.36 | $95.4K | 1,119,402 | |
traded | David P. Hochman Officer (see filing) | Purchase | 10,000 | $4.79 | $47.9K | 1,070,746 | |
traded | Darren Sherman Officer (see filing) | SalePre-arranged (10b5-1) | 15,000 | $4.94 | $74.1K | 1,134,402 | |
traded | Darren Sherman Officer (see filing) | Purchase | 2,000 | $5.33 | $10.7K | 2,000 | |
traded | Darren Sherman Officer (see filing) | SalePre-arranged (10b5-1) | 15,000 | $4.09 | $61.4K | 1,154,327 | |
traded | Darren Sherman Officer (see filing) | SalePre-arranged (10b5-1) | 15,000 | $4.27 | $64.0K | 1,169,327 | |
traded | Darren Sherman Officer (see filing) | SalePre-arranged (10b5-1) | 15,000 | $3.87 | $58.1K | 1,184,327 | |
traded | David P. Hochman Officer (see filing) | Purchase | 5,000 | $3.83 | $19.2K | 1,064,029 | |
traded | Jason Aryeh Director | Purchase | 665 | $3.75 | $2.5K | 118,118 | |
traded | David P. Hochman Officer (see filing) | Purchase | 5,000 | $3.77 | $18.9K | 1,059,029 | |
traded | Jason Aryeh Director | Purchase | 8,971 | $3.90 | $35.0K | 117,453 | |
traded | Eric S. Fain Director | Purchase | 20,000 | $4.13 | $82.6K | 91,709 | |
traded | Roderick Wong 10% owner | Sale | 32 | $4.13 | $132 | 9,556,063 | |
traded | David P. Hochman Officer (see filing) | Purchase | 10,000 | $4.29 | $42.9K | 1,086,467 | |
traded | David P. Hochman Officer (see filing) | Purchase | 5,000 | $4.07 | $20.4K | 612,822 |
GET /stocks/filings/vX/form-4?tickers=OBIO&filing_date.gte=2025-11-10&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"OBIO"
],
"issuer_cik": "0001814114",
"owner_cik": "0001402222",
"accession_number": "0001104659-26-124539",
"form_type": "4",
"filing_date": "2026-11-09",
"period_of_report": "2026-11-09",
"issuer_name": "Orchestra BioMed Holdings, Inc.",
"issuer_trading_symbol": "OBIO",
"owner_name": "Fain Eric S",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock, par value $0.0001 per share",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-09",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 20000,
"transaction_price_per_share": 5,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 119630,
"transaction_value": 100000,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "By the Fain Living Trust",
"footnotes": [
{
"id": "F1",
"description": "These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share."
}
]
},
{
"tickers": [
"OBIO"
],
"issuer_cik": "0001814114",
"owner_cik": "0001722733",
"accession_number": "0001104659-26-124537",
"form_type": "4",
"filing_date": "2026-11-09",
"period_of_report": "2026-11-09",
"issuer_name": "Orchestra BioMed Holdings, Inc.",
"issuer_trading_symbol": "OBIO",
"owner_name": "Pacitti David",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock, par value $0.0001 per share",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-09",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 20000,
"transaction_price_per_share": 5,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 74750,
"transaction_value": 100000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 40 records
- Tax withholding32 records
- Grants and awards7 records
- Other1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
How current is OBIO’s insider data?
These are OBIO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track OBIO insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for OBIO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.